Biocept Inc
BIOCDelisted Nov 20, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001044378
Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Biocept Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- 0 vs. Q4 2022
- Shares held
- 899.3K
- −628.9K (−41.2%) vs. Q4 2022
- Total value
- $304.2K
- −$503.5K (−62.3%) vs. Q4 2022
- New holders
- 5
- 4 more added
- Sold out
- 5
- 9 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIOC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 13 | $218.0K |
| Q2 2023 | 11 | $96.4K |
| Q1 2023 | 26 | $304.2K |
| Q4 2022 | 26 | $807.7K |
| Q3 2022 | 29 | $1.57M |
| Q2 2022 | 29 | $1.78M |
| Q1 2022 | 30 | $4.90M |
| Q4 2021 | 35 | $8.32M |
| Q3 2021 | 29 | $8.12M |
| Q2 2021 | 24 | $6.76M |
| Q1 2021 | 25 | $7.21M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Biocept Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 193,741 | $66.0K | 0.00% | +31,441+19.4% | Added |
| BlackRock Inc. | 157,913 | $53.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 134,112 | $45.6K | 0.00% | −3,386−2.5% | Reduced |
| Bridgeway Capital Management, LLC | 94,200 | $32.0K | 0.00% | −15,236−13.9% | Reduced |
| HRT Financial LP | 55,334 | $18.0K | 0.00% | +55,334 | New |
| State Street Corp | 40,596 | $13.8K | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 29,602 | $10.1K | 0.04% | −900−3.0% | Reduced |
| Northern Trust Corp | 26,818 | $9.12K | 0.00% | 00.0% | Unchanged |
| Taylor & Morgan Wealth Management, LLC | 26,000 | $8.84K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 25,403 | $8.64K | 0.00% | +25,403 | New |
| Susquehanna International Group, LLP | 22,477 | $7.64K | 0.00% | +10,331+85.1% | Added |
| Ergoteles LLC | 22,020 | $7.49K | 0.00% | +22,020 | New |
| Acadian Asset Management LLC | 13,871 | $4.00K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 11,602 | $3.94K | 0.00% | −673−5.5% | Reduced |
| Goldman Sachs Group Inc | 10,903 | $3.71K | 0.00% | +10,903 | New |
| Tower Research Capital LLC (TRC) | 8,369 | $3.00K | 0.00% | −17−0.2% | Reduced |
| Citadel Advisors LLC | 8,209 | $2.79K | 0.00% | −2,187−21.0% | Reduced |
| Group One Trading, L.P. | 8,000 | $2.72K | 0.00% | +7,190+887.7% | Added |
| UBS Group AG | 4,412 | $1.50K | 0.00% | −3,815−46.4% | Reduced |
| Royal Bank of Canada | 3,487 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,000 | $340 | 0.00% | −1,000−50.0% | Reduced |
| US Bancorp | 583 | $198 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 118 | $40 | 0.00% | +2+1.7% | Added |
| FMR LLC | 20 | $7 | 0.00% | +20 | New |
| Simplex Trading, LLC | 475 | $0 | 0.00% | −3,293−87.4% | Reduced |
| Focused Wealth Management, Inc | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 0 | $0 | 0.00% | −617,984−100.0% | Sold out |
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −108,280−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,001−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −540−100.0% | Sold out |